Japan prazosin market is estimated to decline at a CAGR of around -2.6% during the forecast period. Prazosin hydrochloride (a derivative of Prazosin) is reported as an ingredient of Minipress in Japan and is used for the treatment of various diseases including BPH, heart failure, high blood pressure, and Raynaud's syndrome. According to the American Heart Association in 2018, 43 million people in Japan were hypertensive, of which only 50% are treated, and about 25% are controlled at the target blood pressure (BP) level of